ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2733

Decreased CXCR3+CCR4-CCR6+ CD4+ Effector Memory T Cells in Patients with Granulomatosis with Polyangiitis

Lucas L. Lintermans1, Coen A. Stegeman2, Abraham Rutgers1, Peter Heeringa3 and Wayel H. Abdulahad1, 1Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, Netherlands, 2Nephrology, University Medical Center Groningen, Groningen, Netherlands, 3Pathology and Medical Biology, University Medical Center Groningen, Groningen, Netherlands

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Chemokine Receptors and T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: T cell Biology in Lupus, Vasculitis, Myositis and Other Autoimmunity

Session Type: Abstract Submissions (ACR)

Background/Purpose:  Persistent expansion of circulating CD4+ effector memory T cells (TEM) in patients with Granulomatosis with polyangiits (GPA) suggest their fundamental role in disease pathogenesis. The functional phenotype of these CD4+ TEM cells in GPA-patients is not known. Recent studies have shown that 4 distinct functional subsets of CD4+ TEM cell can be identified based on the expression pattern of the chemokine receptors CXCR3, CRTh2, CCR4, and CCR6. The current study aimed to identify functionally reported different phenotypes within the expanded CD4+ TEM cell population in peripheral blood of GPA-patients. 

Methods:  Peripheral blood of 43 GPA-patients in remission and 16 healthy controls (HCs) was stained immediately after blood withdrawal with fluorochrome-conjugated antibodies for cell surface markers (CD3, CD4, CD45RO) and chemokine receptors (CCR4, CCR6, CCR7, CRTh2, CXCR3) followed by flow cytometry analysis. Positively and negatively stained populations were calculated by dot plot analysis, determined by the appropriate isotype controls. Expression patterns of chemokine receptors CXCR3+CRTh2–CCR4–CCR6–, CXCR3–CRTh2+CCR4+CCR6–, CXCR3–CRTh2–CCR4+CCR6+, and CXCR3+CRTh2–CCR4–CCR6+ were used to distinguish Th1, Th2, Th17, and Th1/17 cells, respectively. 

Results:  The percentage of CD4+ TEM (CD3+CD4+CD45RO+CCR7–) cells was significantly increased in GPA-patients in remission compared to HCs (median 41,93% vs 31,52%). Chemokine receptor co-expression analysis within the CD4+ TEM cell population demonstrated similar percentages of Th1 and Th2 cells between GPA-patients and HCs. Interestingly, the analysis revealed a significant decrease in the frequency of Th1/17 cells (median 9,28% vs 16,53%) with a concomitant significant increase in the Th17 cells (median 21,14% vs 16,93%) in GPA-patients compared to HCs. However, differences between these CD4+ TEM cell subsets were not related to generalized or localized disease, ANCA positivity at the time of inclusion, nor to immunosuppressive treatment regimens. 

Conclusion:  Based on chemokine receptor co-expression analysis we demonstrate an aberrant distribution in the CD4+ TEM cell compartment in GPA-patients. The identification of different phenotypes within the expanded CD4+ TEM cell population revealed a distinction between Th1/17 cells and Th17 cells. Interestingly, it has been described that the functional and molecular signature of Th1/17 cells is associated with a strong pathogenicity of this subset and may be important in mediating chronic inflammation. Analyzing the migration capacity of Th1/17 cells might reveal their distinct tissue homing characteristic to inflamed lesions in GPA-patients.


Disclosure:

L. L. Lintermans,
None;

C. A. Stegeman,
None;

A. Rutgers,
None;

P. Heeringa,
None;

W. H. Abdulahad,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/decreased-cxcr3ccr4-ccr6-cd4-effector-memory-t-cells-in-patients-with-granulomatosis-with-polyangiitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology